Transient receptor potential vanilloid 4 (TRPV4) is a Ca2+-permeable non-selective cation channel and will end up being activated during ischemia/reperfusion (We/R). inhibitors. We conclude that blockade of TRPV4 decreases apoptosis via the activation of RISK pathway, and for that reason may be a appealing technique to prevent myocardial I/R damage. TSPAN6 Ischemia cardiovascular disease is… Continue reading Transient receptor potential vanilloid 4 (TRPV4) is a Ca2+-permeable non-selective cation